Human Papilloma Virus (HPV) Vaccination
Cervical Cancer affects the neck of the womb (cervix) and is most common in 30-49 yr age group. Its prevalence is about 2000 new cases per year but this is decreasing as the national cervical screening programme becomes more successful. Cervical cancer develops from abnormal cells. The cells become abnormal after they have been infected with Human Papilloma Virus (HPV). This is a very common virus, which many people will be exposed to in their life (only passed on through sexual intercourse). There a number of sub-types of the virus but it is believed that only certain ones cause diseases such as cervical cancer and genital warts. Only a small proportion of people who are infected with HPV will develop any form of disease/condition.
Provision of HPV vaccination
We would recommend all those eligible for the national programme to have their vaccination through the NHS. Those outside the government’s criteria can access either vaccine privately. We can vaccinate you whether you are registered with UNHS or not.
Gardasil and Cervarix do not protect those receiving it from all types of HPV infection or all cervical cancers. It is essential females continue to participate in the national screening programme at the appropriate age.
Gardasil and Cervarix are not licensed for use in pregnancy.